Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ZYME · against 557 other Healthcare companies listed in US-listed
Ranked #490 of 558 · scores higher than 11% of peers
Bars: peers in each 10-point band of the profitability score100 peers with a profitability score of 0–9, including ZYME · Click a bar to see the companies
Mainly because of its operating margin and return on assets, which are weaker than most Healthcare peers.
| Metric | ZYME | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 517 reported | Not reported | -7.0% | — | — | 33% |
| Operating marginHigher is better · 479 reported | -419.0% | -2.4% | 15% | 33% | |
| Return on assetsHigher is better · 582 reported | -37.8% | -7.8% | 22% | 33% | |
| Return on equityHigher is better · 531 reported | -72.3% | -19.7% | 20% | Context only | |
| Gross marginHigher is better · 601 reported | -246.7% | 43.9% | 1% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 595M USD | 99 | 97 | |
| 1 | 433M USD | 99 | 81 | |
| 1 | 17.9B USD | 99 | 76 | |
| 1 | 52.9B USD | 99 | 57 | |
| 1 | 578M USD | 99 | 73 | |
| 490 | 1.5B USD | 6 | 30 | |
| 490 | 26.0B USD | 6 | 28 | |
| 490 | 354M USD | 6 | 13 | |
| 490 | 314M USD | 6 | 56 | |
| 490 | 2.2B USD | 6 | 20 | |
| 498 | 397M USD | 5 | 37 | |
| 498 | 389M USD | 5 | 33 | |
| 498 | 274M USD | 5 | 57 | |
| 498 | 5.7B USD | 5 | 52 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score